
Albert Mark Navarro
Examiner (ID: 6665)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1621, 1817, 1645, 2899 |
| Total Applications | 2107 |
| Issued Applications | 1529 |
| Pending Applications | 202 |
| Abandoned Applications | 409 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19447337
[patent_doc_number] => 20240307467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => MATRIX FORMULATED WITH PROBIOTICS FOR USE IN THE TREATMENT OF CARIES
[patent_app_type] => utility
[patent_app_number] => 18/274950
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274950
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274950 | MATRIX FORMULATED WITH PROBIOTICS FOR USE IN THE TREATMENT OF CARIES | Oct 27, 2021 | Pending |
Array
(
[id] => 18634916
[patent_doc_number] => 11759487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Composition including probiotics and method of increasing amount of oral immunoglobulin A and inhibiting oral pathogens by administering the same
[patent_app_type] => utility
[patent_app_number] => 17/511689
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 8019
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/511689 | Composition including probiotics and method of increasing amount of oral immunoglobulin A and inhibiting oral pathogens by administering the same | Oct 26, 2021 | Issued |
Array
(
[id] => 17385944
[patent_doc_number] => 20220033796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
[patent_app_type] => utility
[patent_app_number] => 17/505537
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17505537
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/505537 | Process and system for obtaining botulinum neurotoxin | Oct 18, 2021 | Issued |
Array
(
[id] => 18815216
[patent_doc_number] => 20230389554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => METHODS FOR THE PREPARATION OF NON-LIVE CHROMOBACTERIUM BIOPESTICIDE
[patent_app_type] => utility
[patent_app_number] => 18/249293
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249293
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/249293 | METHODS FOR THE PREPARATION OF NON-LIVE CHROMOBACTERIUM BIOPESTICIDE | Oct 17, 2021 | Pending |
Array
(
[id] => 17441676
[patent_doc_number] => 20220062181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => COMPOSITIONS AND METHODS FOR LYOPHILIZATION OF BACTERIA OR LISTERIA STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/503647
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503647 | Compositions and methods for lyophilization of bacteria or listeria strains | Oct 17, 2021 | Issued |
Array
(
[id] => 20413058
[patent_doc_number] => 12496320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 18/032893
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 1604
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032893
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032893 | NOVEL LACTOBACILLUS SP. STRAIN AND USE THEREOF | Oct 13, 2021 | Issued |
Array
(
[id] => 20413058
[patent_doc_number] => 12496320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 18/032893
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 1604
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032893
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032893 | NOVEL LACTOBACILLUS SP. STRAIN AND USE THEREOF | Oct 13, 2021 | Issued |
Array
(
[id] => 17369943
[patent_doc_number] => 20220024995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Method for the Treatment of a Relapsing-Remitting Condition
[patent_app_type] => utility
[patent_app_number] => 17/499753
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499753 | Method for the acute treatment of atopic dermatitis and allergic skin hypersensitivity | Oct 11, 2021 | Issued |
Array
(
[id] => 18786078
[patent_doc_number] => 20230374063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => METHODS FOR REDUCING HOST CELL PROTEIN CONTENT IN PROTEIN PURIFICATION PROCESSES
[patent_app_type] => utility
[patent_app_number] => 18/247084
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247084
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247084 | METHODS FOR REDUCING HOST CELL PROTEIN CONTENT IN PROTEIN PURIFICATION PROCESSES | Oct 3, 2021 | Pending |
Array
(
[id] => 18786078
[patent_doc_number] => 20230374063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => METHODS FOR REDUCING HOST CELL PROTEIN CONTENT IN PROTEIN PURIFICATION PROCESSES
[patent_app_type] => utility
[patent_app_number] => 18/247084
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247084
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247084 | METHODS FOR REDUCING HOST CELL PROTEIN CONTENT IN PROTEIN PURIFICATION PROCESSES | Oct 3, 2021 | Pending |
Array
(
[id] => 19338565
[patent_doc_number] => 12048736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Sea lice vaccine
[patent_app_type] => utility
[patent_app_number] => 17/491924
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 39
[patent_no_of_words] => 16192
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491924 | Sea lice vaccine | Sep 30, 2021 | Issued |
Array
(
[id] => 18707582
[patent_doc_number] => 20230330159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => COMPOSITION FOR DIAGNOSIS OR TREATMENT OF INFLAMMATORY DISEASES, COMPRISING MICROORGANISM
[patent_app_type] => utility
[patent_app_number] => 18/028913
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028913
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/028913 | COMPOSITION FOR DIAGNOSIS OR TREATMENT OF INFLAMMATORY DISEASES, COMPRISING MICROORGANISM | Sep 26, 2021 | Pending |
Array
(
[id] => 17343963
[patent_doc_number] => 20220010294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => NOVEL RECOMBINANT BOTULINUM NEUROTOXINS WITH INCREASED DURATION OF EFFECT
[patent_app_type] => utility
[patent_app_number] => 17/482953
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482953
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482953 | NOVEL RECOMBINANT BOTULINUM NEUROTOXINS WITH INCREASED DURATION OF EFFECT | Sep 22, 2021 | Abandoned |
Array
(
[id] => 17342192
[patent_doc_number] => 20220008523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => PEPTIDE CONJUGATED PARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/482043
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482043
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482043 | PEPTIDE CONJUGATED PARTICLES | Sep 21, 2021 | Pending |
Array
(
[id] => 17775059
[patent_doc_number] => 20220241408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/477739
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17477739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/477739 | QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF | Sep 16, 2021 | Abandoned |
Array
(
[id] => 18784777
[patent_doc_number] => 20230372409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => SOLID DOSAGE FORMS OF BACTERIA
[patent_app_type] => utility
[patent_app_number] => 18/027003
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -116
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027003
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/027003 | SOLID DOSAGE FORMS OF BACTERIA | Sep 16, 2021 | Pending |
Array
(
[id] => 17334614
[patent_doc_number] => 20220000945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => METHODS FOR COLONIZING WITH BENEFICIAL ORAL BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/477380
[patent_app_country] => US
[patent_app_date] => 2021-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17477380
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/477380 | Methods for colonizing with beneficial oral bacteria | Sep 15, 2021 | Issued |
Array
(
[id] => 17783570
[patent_doc_number] => 11406675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Therapeutic pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/475228
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 36
[patent_no_of_words] => 34074
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17475228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/475228 | Therapeutic pharmaceutical compositions | Sep 13, 2021 | Issued |
Array
(
[id] => 17312703
[patent_doc_number] => 20210401751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPOSITIONS FOR TREATING VIRAL INFECTIONS AND METHODS FOR SAME
[patent_app_type] => utility
[patent_app_number] => 17/472750
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472750 | Compositions for treating viral infections and methods for same | Sep 12, 2021 | Issued |
Array
(
[id] => 17312915
[patent_doc_number] => 20210401963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSTION
[patent_app_type] => utility
[patent_app_number] => 17/471825
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471825
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471825 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Sep 9, 2021 | Issued |